Skip to main content

Table 2 Stone composition

From: The role of specific biomarkers, as predictors of post-operative complications following flexible ureterorenoscopy (FURS), for the treatment of kidney stones: a single-centre observational clinical pilot-study in 37 patients

Main constituent of stone(s) Patients
Calcium oxalate monohydrate 21
Calcium phosphate stones 7
Cystine stones 3
Calcium hydroxyl phosphate 3
Calcium-oxalate dihydrate stones 3